Blue Jet Healthcare Ltd (NSE:BLUEJET)
₹ 569.8 -9.2 (-1.59%) Market Cap: 107.73 Bil Enterprise Value: 104.91 Bil PE Ratio: 42.00 PB Ratio: 7.26 GF Score: 65/100

Q1 2026 Blue Jet Healthcare Ltd Earnings Call Transcript

Jul 22, 2025 / 11:30AM GMT
Release Date Price: ₹906.15 (-10.00%)

Key Points

Positve
  • Revenue from operations increased by 118% year-on-year, reaching INR3,548 million, driven by consistent volume growth across PI, API, and contract media platforms.
  • EBITDA grew by 178% year-on-year, reflecting strong base volume expansion and enhanced operational scale.
  • The company completed Phase 2 expansion in Unit 2, which is now fully operational, and progress continues at Unit 3 Mahad, on schedule for H2 FY26 commission.
  • Blue Jet Healthcare Ltd (NSE:BLUEJET) has committed INR400 million towards R&D capabilities in amino acid derivatives and estate intermediates.
  • The company maintains a strong outlook for FY26, with healthy demand visibility across key customers and expanded product pipelines.
Negative
  • EBITDA margin decreased to 34% due to phasing of production, inventory normalization, and product mix.
  • Gross margin for the quarter was 48.5%, down by 6.5% from the previous quarter, attributed to inventory adjustments and product mix changes.
  • Contrast Media segment saw a 3.9% quarter-over-quarter dip, mainly due to phasing, although the outlook remains positive.
  • The company experienced a one-time demand impact of INR27 million, affecting EBITDA by approximately 0.7%.
  • There was a muted Forex gain due to US dollar depreciation in Q1, impacting financial performance.
Operator

Ladies and gentlemen, good day, and welcome to the Q1 FY26 earnings conference call of Blue Jet Healthcare. (Operator Instructions)

I now hand the conference over to Mr. Advait Bhadekar. Thank you, and over to you, sir.

Advait Bhadekar
Ernst & Young Global Limited - Analyst

Thank you, Viren. Good evening and a warm welcome, everyone, to Q1 FY26 earnings call of Blue Jet Healthcare Limited. Please note, the investor presentation and the financial results are available on the company website and the stock exchanges. Also, anything said on this call, which reflects our outlook for the future or which could be construed as a forward-looking statement must be reviewed in conjunction with the risks that the company faces.

The conference call is being recorded, and the transcript along with the audio of the same will be made available on the website of the company as well as on the exchanges. Please also note that the audio of the conference call is the copyright material of Blue Jet Healthcare Limited and cannot be copied, rebroadcasted or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot